WHO ICTRP trial

Isobaric levobupivacaine with adjuvant in thoracic spinal for upper abdominal…

CTRI/2025/04/084541 · Clinical Trials Registry India (CTRI) · Not Recruiting

Key facts

Trial ID CTRI/2025/04/084541
Public title Isobaric levobupivacaine with adjuvant in thoracic spinal for upper abdominal surgeries for early recovery and long duration of post operative pai n relief
Scientific title Isobaric levobupivacaine versus isobaric levobupivacaine with dexmedetomidine in segmental spinal anaesthesia in patients undergoing upper abdominal surgeries. A Randomised study. - NIL
Primary sponsor AIIMS bibinagar
Registry Clinical Trials Registry India (CTRI)
Recruitment status Not Recruiting
Study type Interventional
Countries India
Conditions Health Condition 1: K420- Umbilical hernia with obstruction,without gangrene
Interventions Intervention1: 0.5% Isobaric Levobupivacaine 1.5ml with 5 mcg dexemedetomidine: will be given in segmental spinal anaesthesia for surgical procedure and outcomes measured for 24 hours Control Intervention1: Isobaric Levobupivacaine: 0.5%…
Registration date Nov 4, 2025
Target size 60
Secondary IDs NIL
Registry page ctri.nic.in

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations